Prostate Cancer Therapeutics : Advent of Generic Drugs to Drive Growth as Blockbuster Therapeutics Go Off-patent in Global Market 2017

Albany, New York, June 23, 2017 : Recent research and the current scenario as well as future market potential of "Prostate Cancer Therapeutics Market (Therapy Type - Hormone Therapy {Luteinizing Hormone-Releasing Hormone Analogs, Luteinizing Hormone-Releasing Hormone Antagonists, and Antiandrogens}, Chemotherapy {Systemic Chemotherapy and Regional Chemotherapy}, Biologic Therapy, and Targeted Therapy); Distribution Channel - Hospital Pharmacy, Retail Pharmacy, and Online Sales - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2016 - 2024" globally.

This report on the prostate cancer therapeutics market analyzes the current and future scenario of the global market. Increasing prevalence of prostate cancer, launch of promising emerging therapies, as well as innovation in the development of new drugs & therapeutic biological products, and high growth in hormone-refractory prostate cancer drug due to lesser side effects are some of the drivers expected to drive the global prostate cancer therapeutics market during the forecast period.

Get PDF for more Professional and Technical insights @ http://www.researchmoz.us/enquiry.php?type=S&repid=1064481

The global prostate cancer therapeutics market report comprises an elaborate executive summary, which includes market snapshot that provides information about various segments. It also provides information and data analysis of the country’s market with respect to the segments based on therapy type, distribution channels and regions. A detailed qualitative analysis of drivers and restraints, opportunities, and trends has been provided in the market overview section. Additionally, the section comprises Porters Five Forces Analysis to help understand the competitive landscape in the market. This section also provides market attractiveness analysis in terms of country and market share analysis by key players, thus presenting a thorough analysis of the overall competitive scenario in the global prostate cancer therapeutics market.

Global Prostate Cancer Therapeutics Market: Key Segments

Based on therapy type, the market has been segmented into hormone therapy, chemotherapy, biologic therapy and targeted therapy. The market segments have been analyzed based on available approved products, cost-effectiveness, and preference from oncologists for treating the prostate cancer with various drug classes. The market size and forecast for each of these segments have been provided for the period from 2014 to 2024, along with their respective CAGRs for the forecast period from 2016 to 2024, considering 2015 as the base year.

Based on distribution channels, the global prostate cancer therapeutics market has been segmented into hospital pharmacy, retail pharmacy, online sales and others. The market segments have been extensively analyzed based on increase in demand for disease treatment among prostate cancer patients. Increased patient hospitalization for the treatment of prostate cancer are driving the market share of hospital pharmacy segment. The market size and forecast in terms of US$ Mn for each segment have been provided for the period from 2014 to 2024. The report also provides the compound annual growth rate (CAGR %) for each market segment for the forecast period from 2016 to 2024, considering 2015 as the base year.

Global Prostate Cancer Therapeutics Market: Regional Outlook

Geographically, the global prostate cancer therapeutics market on the basis of region has been segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. The market size and forecast for each of these regions have been provided for the period from 2014 to 2024, along with their respective CAGRs for the forecast period from 2016 to 2024, considering 2015 as the base year.

Companies Mentioned in Report

The report also profiles major players in the global prostate cancer therapeutics market based on various attributes such as company overview, financial overview, product portfolio, business strategies, SWOT analysis, and recent developments. Major players profiled in this report include players in the global prostate cancer therapeutics market are Amgen, Inc., Johnson & Johnson (Janssen Biotech, Inc.), Pfizer, Inc., AstraZeneca, AbbVie, Inc., Bayer AG, Ipsen Group, Sanofi, Endo Pharmaceuticals, Inc., Dendreon Corporation (Sanpower Group Co. Ltd.) and others.

The Global Prostate Cancer Therapeutics Market is segmented as given below:

Global Prostate Cancer Therapeutics Market, by Therapy

Hormone Therapy
Luteinizing Hormone-Releasing Hormone Analogs
Luteinizing Hormone-Releasing Hormone Antagonists
Antiandrogens
Chemotherapy
Systemic Chemotherapy
Regional Chemotherapy
Biologic Therapy
Targeted Therapy

Make an Enquiry of this report @ http://www.researchmoz.us/enquiry.php?type=E&repid=1064481

Global Prostate Cancer Therapeutics Market, by Distribution Channel

Hospital Pharmacy
Retail Pharmacy
Online Sales
Others

Global Prostate Cancer Therapeutics Market, by Geography

North America
U.S.
Canada
Europe
Germany
U.K.
Italy
France
Spain
Russia
Rest of Europe
Asia Pacific
Japan
India
China
Australia & New Zealand
Rest of Asia Pacific
Latin America
Brazil
Mexico
Rest of Latin America
Middle East & Africa
Saudi Arabia
South Africa
UAE
Rest of Middle East & Africa

ResearchMoz is the one stop online destination to find and buy market research reports & Industry Analysis. We fulfill all your research needs spanning across industry verticals with our huge collection of market research reports. We provide our services to all sizes of organizations and across all industry verticals and markets. Our Research Coordinators have in-depth knowledge of reports as well as publishers and will assist you in making an informed decision by giving you unbiased and deep insights on which reports will satisfy your needs at the best price.

ResearchMoz
90 State Street,
Albany, NY 12207,
United States

This release was published on openPR.